Labshake search
Citations for R&D Systems :
301 - 350 of 3395 citations for Oxychlordane Unlabeled 100 Ug Ml In Methanol since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... were coated with 100 μl per well of 1.5 μg/ml human recombinant integrin αvβ6 (R&D Systems) diluted in coating buffer from the ELISA Starter Accessory Kit (Bethyl Laboratories ...
-
bioRxiv - Systems Biology 2021Quote: Cultured cells were stimulated with Wnt-3A CM or 100 ng/ml recombinant mouse Wnt-3A (R&D Systems) for the indicated times ...
-
bioRxiv - Systems Biology 2021Quote: Cultured cells were stimulated with Wnt-3A CM or 100 ng/ml recombinant mouse Wnt-3A (R&D Systems) for the indicated times ...
-
bioRxiv - Physiology 2021Quote: ... The medium was supplemented with 100 ng/mL recombinant human M-CSF using CellXVivo™ kit (R&D Systems) and differentiated for 5–7 days prior to use.
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with 10 ng ml−1 of recombinant human IFNγ (R&D Systems, 285-IF-100), 10 ng ml−1 of recombinant human TNFα (R&D Systems ...
-
bioRxiv - Bioengineering 2019Quote: Stage 1: 3 days in S1 basal media with 100 ng/ml Activin A (R&D Systems; 338-AC) and 3 μM CHIR99021 (Stemgent ...
-
bioRxiv - Neuroscience 2019Quote: ... while oculomotor neurons were patterned by SAG (250 nM) and Fgf8 (100 ng/ml, #423-F8 R&D systems) for 5 days ...
-
bioRxiv - Neuroscience 2022Quote: ... 100 µL of a solution containing 0.001 mg/mL of the detection biotinylated polyclonal antibody (BAF1559; R&D Systems) raised against NOTCH3 ECD and 2.5% BSA was added and was used for detection followed by agitation for 2h at RT ...
-
bioRxiv - Cell Biology 2024Quote: ... the samples were serum-starved for 12 h and then treated with 100 ng/ml BMP2 (R&D Systems) for 3 h ...
-
bioRxiv - Developmental Biology 2020Quote: ... At day 1 the medium was changed to base media supplemented with Activin A (100 ng/ml, R&D Systems), basic FGF (bFGF ...
-
bioRxiv - Developmental Biology 2021Quote: ... At day 1 the medium was changed to SFD media supplemented with Activin A (100 ng/ml, R&D Systems), basic FGF (bFGF ...
-
bioRxiv - Neuroscience 2022Quote: ... cells were stimulated with a pro-inflammatory cocktail of 20ng/ml interferon-γ (IFNγ, R&D Systems #485-MI-100) and 50ng/ml tumor necrosis factor α (TNFα ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were incubated in cSFDM (with RA-containing B27 supplement) with 100 ng/ml rhFGF2 (R&D Systems, #233-FB), 100 ng/ml rhFGF10 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... MDMs were stimulated in complete RPMI with either 10 ng/mL human IFN-ψ (285-IF-100, R&D Systems) or 50 ng/mL LPS ...
-
bioRxiv - Biochemistry 2023Quote: ... were grown on a plate coated by Cultrex Rat Collagen I (50 µg/ml, R&D systems 3440-100-01) at 37°C in 5% CO2 in high glucose-containing DMEM (Corning 10-013-CM ...
-
bioRxiv - Neuroscience 2024Quote: ... Wells were flooded with BrainPhys media with supplements and 10 ng/mL human NGF (256-GF-100, R&D Systems), and 3 μg/mL FRDU and incubated at 37° C and 5% CO2 until further experimentation.
-
bioRxiv - Microbiology 2020Quote: HTBE and A549 cells were seeded overnight and then treated with 100 IU/ml universal interferon beta (IFN, R&D Systems), or left untreated ...
-
bioRxiv - Immunology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC).
-
bioRxiv - Cell Biology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC). Fully differentiated macrophages were harvested and seeded at the required density for the subsequent experiments.
-
bioRxiv - Neuroscience 2022Quote: ... The tri-culture medium consisted of supplementing the co-culture medium with 100 ng/mL mouse IL-34 (R&D Systems), 2 ng/mL TGF-β (Peprotech) ...
-
bioRxiv - Immunology 2023Quote: ... K562 cells were stimulated in complete RPMI media with 20 ng/mL human IFN-ψ (285-IF-100, R&D Systems), 20 ng/mL human IFN-β (84-99I-F010 ...
-
bioRxiv - Immunology 2023Quote: ... HUT78 cells were stimulated in complete IMDM media with 20 ng/mL human IFN-ψ (285-IF-100, R&D Systems). All treatments were 24 hours.
-
bioRxiv - Neuroscience 2021Quote: ... These rats were then administered 50 μl of NRG-1β (1% BSA in PBS) or 50 μl of vehicle (1% BSA in PBS) treatment (20 ug/kg; EGF-like domain, R&D Systems, Minneapolis, MN) via bolus injection into the ICA through the ECA immediately before MCAO ...
-
bioRxiv - Bioengineering 2019Quote: ... 2013] consisting of the osteogenic media supplemented with 100 ng/mL BMP-2 (recombinant human BMP-2, 355-BM-050, R&D Systems). Media was replaced every 3 days ...
-
bioRxiv - Microbiology 2020Quote: ... hESCs were cultured to achieve 80-90% confluency, and treated with 3 μM CHIR99021 (CHIR, Stem-RD) and 100 ng/ml Activin A (R&D systems) in basal medium RPMI1640 (Cellgro ...
-
bioRxiv - Cell Biology 2022Quote: ... monolayers grown with the differentiation media for 7 days were stimulated with human IFNβ (100 or 300 IU/ml, R&D systems) or IFNλ2 (10 or 30 ng/ml ...
-
bioRxiv - Biochemistry 2020Quote: In vitro co-precipitation of TREM2 or TREM1 with Aβ oligomers was performed by mixing recombinant Fc-tagged TREM2 or TREM1 ectodomain (residues 19-171; 100 ng/ml, R&D systems), 100 nM HiLyte Fluor 647-labelled Aβ oligomers and Protein G Dynabeads in 0.5% fatty acid free BSA PBS-Tween buffer ...
-
bioRxiv - Microbiology 2022Quote: ... Using density gradient medium (Lymphoprep) monocytes were isolated and differentiated into macrophages in the presence of GM-CSF (100 ng/mL) (R&D Systems) in 1640 RPMI + 5% FBS +P/S media for 6 to 7 days
-
bioRxiv - Immunology 2020Quote: ... 5 × 105 cells in 100 μl adhesion buffer were added to the upper chamber and either 500 ng/ml CCL2 (R&D Systems) or 10 nM C5a (R&D Systems ...
-
bioRxiv - Developmental Biology 2021Quote: ESCs were then differentiated into anteriormost primitive streak through the addition of CDM2 basal medium supplemented with Activin A (100 ng/mL; R&D Systems), CHIR99021 (3 µM ...
-
bioRxiv - Developmental Biology 2021Quote: ... and then differentiated into day 2 definitive endoderm through the addition of CDM2 basal medium supplemented with Activin A (100 ng/mL; R&D Systems), LDN-193189 (250 nM ...
-
bioRxiv - Developmental Biology 2021Quote: ... cells were exposed to 1 µM EdU along with or withpout 2-100 ng/ml recombinant VEGFA (R&D Systems, 493-MV) for 8 hours before being fixed and stained by the Click-iT EdU Alexa Fluor 488 Imaging Kit (Thermo Scientific ...
-
bioRxiv - Microbiology 2020Quote: ... the cells were incubated with either M1-activation medium [RPMI160 medium with 20 ng/ml IFNγ (485-MI-100; R&D systems) and 10 ng/ml LPS (L2630 ...
-
bioRxiv - Cell Biology 2021Quote: LECs were pre-cultured with FBS-free and supplement-free basal medium for 24 h and then treated with medium containing 100 ng/mL of recombinant rat CTGF (R&D Systems) for 5 min ...
-
bioRxiv - Immunology 2022Quote: ... Monocyte differentiation into macrophages was performed for 5-7 days in the presence of human M-CSF (100 ng/ml) (R&D system). On the day of the assay ...
-
bioRxiv - Bioengineering 2022Quote: The preosteoblast cells cultured in tissue culture plates were differentiated for 5 days and treated with Myostatin of 100 ng/mL (788-G8-010/CF R&D system), follistatin of 100 ng/mL (769-FS-025/CF ...
-
bioRxiv - Genetics 2023Quote: Reprogramming was done as described previously, combining the IFNγ (10 ng/ml, day 0 to 5) (R&D Systems, 485-MI-100) with the addition of the TET inhibitor molecule Bobcat 339 (concentration of 5 µM ...
-
bioRxiv - Cell Biology 2023Quote: ... The medium was changed daily for the next three days to DMEM/F12 supplemented with 100 ng/ml recombinant Activin-A (R&D Systems), 100 ng/ml fibroblast growth factor-2 (FGF2 ...
-
bioRxiv - Immunology 2024Quote: ... cells from BM (femora and tibiae) obtained from C57BL/6J mice were plated with 100 ng/ml or recombinant Flt3L (R&D systems) in RPMI1640 medium (Gibco ...
-
bioRxiv - Developmental Biology 2020Quote: ... Primary antibodies Nkx6.1 (1:100, DSHB) and Pdx1 (1:100, R&D Systems) were added and incubated for 30 minutes ...
-
bioRxiv - Immunology 2023Quote: ... KIR2DL1 (PE or APC, clone #143211, R&D systems, FAB1844P-100, FAB1844A-100), KIR2DS4 (PE-Cy7 ...
-
bioRxiv - Evolutionary Biology 2020Quote: ... to evacuate all mTeSR1 and then were treated for 24 hours with Activin A (100 ng/mL, R&D Systems, 338-AC-010), CHIR99021 (2 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... 100 µl of supernatant samples and standards (recombinant mouse TREM2-FC, 1729-T2; R&D Systems; 0-20 ng/ml in BSA-PBST) were then incubated for 2 hr at RT ...
-
bioRxiv - Cell Biology 2021Quote: ... Spain) and supplemented with each one of the following combinations of growth factors: (i) 100 ng/ml Act A (R&D Systems, UK), (ii ...
-
bioRxiv - Neuroscience 2020Quote: ... in culture medium with recombinant mouse TNF-α (10 ng/ml from a stock solution of 100 μg/ml made up in 0.2 % bovine serum albumin and sterile PBS, R&D systems, aa-80325) to stimulate release of inflammatory mediators (TNF-FLS ...
-
bioRxiv - Cancer Biology 2023Quote: ... HUES8 cells were treated with 3μM CHIR99021 (CHIR, Stem-RD, Hoover, AL) and 100 ng/mL Activin A (AA, R&D systems, Minneapolis, MN) in RPMI media (Cellgro ...
-
bioRxiv - Cancer Biology 2021Quote: ... the culture media were replaced with fresh media (DMEM + 10% FBS) supplemented with 0.03 ng ml−1 of recombinant mouse IFNγ (R&D Systems, #485-MI-100). Total RNA from untreated cells (24 h ...
-
bioRxiv - Cancer Biology 2021Quote: ... the culture media were replaced with fresh media (DMEM + 10% FBS) supplemented with 0.03 ng ml−1 of recombinant mouse IFNγ (R&D Systems, #485-MI-100). After 24 h treatment ...
-
bioRxiv - Cancer Biology 2020Quote: ... PBS or conditioned media from lung stromal cells from HFD-fed mice treated with 5 μg/mL of either CSF2 neutralizing antibodies (R&D Systems, MAB415-100) or rat IgG antibodies (R&D Systems ...
-
bioRxiv - Bioengineering 2019Quote: hESCs were differentiated to SC-β cells as previously described9 by culturing in the following conditions in order: Stage 1: 3 d with 100 ng/ml Activin A (R&D Systems; 338-AC) and 3 μM CHIR99021 (Stemgent ...